| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $25.0M | — | -17.5% |
| Cost of Revenue | $18.2M | — | -10.4% |
| Gross Profit | $6.9M | — | -31.9% |
| R&D Expense | $1.4M | — | +1.3% |
| SG&A Expense | $4.0M | — | +20.8% |
| Operating Income | -$2.7M | — | -260.4% |
| Pre-tax Income | -$2.2M | — | -228.2% |
| Income Tax | $22K | — | +160.6% |
| Net Income | -$2.2M | — | -230.1% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $26.8M | -5.5% | +42.1% |
| Short-term Investments | $2K | +0.0% | +0.0% |
| Accounts Receivable | $1.8M | +66.7% | -10.2% |
| Current Assets | $33.7M | +10.7% | +57.1% |
| Total Assets | $87.9M | +23.1% | +54.6% |
| Current Liabilities | $15.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.4M | — | -140.0% |
| Capital Expenditures | $12K | — | +203.8% |
| Investing Cash Flow | $3.5M | — | +138.9% |
| Financing Cash Flow | $1.0M | — | +50.5% |
| Free Cash Flow | -$2.4M | — | -140.2% |
| +65.1% |
| Total Liabilities | $15.6M | +5.8% | +65.1% |
| Stockholders' Equity | $72.3M | +27.6% | +52.5% |